Table 2—

Association of central obesity/metabolic syndrome groups with risk of IHD

n of events (%)Person-yearsIncidence rate (per 1,000 person-years)HR (95% CI)*HR (95% CI)
Including diabetic patients
    No MetS44 (1.4)31,3181.4 (0.9–1.8)1.01.0
    CO/MetS59 (7.7)6,7168.8 (6.6–11.0)6.1 (4.1–9.0)2.8 (1.8–4.2)
    No CO/MetS32 (8.7)3,3669.5 (6.5–13.4)6.7 (4.2–10.6)2.5 (1.5–4.0)
    CO/ MetS vs. no CO/MetS0.9 (0.6–1.4)1.0 (0.6–1.5)
Excluding diabetic patients
    No MetS40 (1.3)30,5411.3 (0.9–1.7)1.01.0
    CO/MetS38 (6.7)5,0137.6 (5.2–10.0)5.6 (3.6–8.8)2.5 (1.6–4.2)
    No CO/MetS18 (6.8)2,4537.3 (4.3–11.5)5.5 (3.2–9.7)1.9 (1.0–3.3)
    CO/MetS vs. no CO/MetS1.0 (0.6–1.8)1.2 (0.8–1.5)
  • *

    * Unadjusted HRs.

  • Adjusted HRs for age, study, ethnic group, sex, LDL cholesterol, smoking (nonsmoker vs. current smoker), and alcohol intake (none/occasional vs. ≥1/month). CO, central obesity; MetS, metabolic syndrome.